Tag: Precision medicine

news-28102024-163033

David Epstein launches new cancer startup after Novartis and Seagen career

David Epstein, who previously served as the CEO of Seagen, has launched a new cancer startup called Ottimo Pharma. The company aims to develop...
news-20102024-151040

Exploring R&D Strategies of Amgen, Biogen, and Takeda for Challenging Targets

Amgen, Biogen, and Takeda are three biopharma companies facing challenges in developing treatments for obesity and Alzheimer's disease. At the STAT 2024 Summit in...

BREAKING NEWS

Top News